Prior to establishing the Sage Group, Mr. Ramseier was President and Chief Executive Officer of OncoTherapeutics, an early stage, private biopharmaceutical company focusing on innovative, immunotherapeutic approaches to cancer, located in Cranbury , NJ . He was instrumental in relocating OncoTherapeutics from its founding site in Minneapolis to New Jersey in 1993, recruiting the core management team and securing the company's first round (post-seed) of venture capital financing in excess of $8 million. OncoTherapeutics was acquired by Biomira in 1995.

From 1990 to 1992, Mr. Ramseier was President of G.V. Ramseier & Associates, an independent consulting firm located in San Diego, CA, which specialized in senior level strategic management consulting to the biomedical and biopharmaceutical industries.

From 1986 to 1990, he was President and CEO of ImmuneTech Pharmaceuticals, Inc., of San Diego. He played a key role in ImmuneTech's 1989 strategic redirection and acquisition of DURA Pharmaceuticals, Inc., for which the entire company was renamed in 1991. Dura Pharmaceuticals was acquired by Elan Pharmaceuticals in 2000 for $1.8 billion. He served as a member of the Dura Board of Directors from 1986-2000.

From 1979-1986, Mr. Ramseier was a partner in the Healthcare Industries Practice of Booz, Allen & Hamilton, Management Consultants, specializing in business strategy and marketing issues in a wide variety of healthcare industry sectors.

He was formerly Director of Marketing, Gynecological Products at G.D. Searle (1975-1979); and a Product Manager at Pfizer Laboratories (1971-1973). He received his M.B.A. (With Distinction) from the Amos Tuck School of Business Administration, Dartmouth College and his B.S. in Chemistry from Washington & Lee University .